Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Daily Grime - Liontrust (LIO), Argentex (AGFX), Alpha (AFMC) Results

Published 20/11/2019, 08:35
Updated 09/07/2023, 11:32

Liontrust Asset Management (LON:LIO) – H1 Results

Share Price 896p

Mkt Cap £491m

Conflict Disclosure: No Holding

  • Results Adjusted PBT up 17% to £17m. AUM at 18 November has increased a further 3% from 30 September to £17.9bn. With performance consistently strong across the funds and net inflows top of the charts there is little to see here. Except for the stripping out of the £4.5n share incebtivisation expense of £4.5m and the costs relating to consolidating the fund services provider to BONY of £1.4m. It could be argued they are ordinary costs of running the business. Outlook is confident of continued momentum.
  • Estimates PBT of £38.3m is expected for the full year. This looks in line with the £17m delivered in H1 and the acquisition of Neptune at the end of H1 adding 18% to AUM.
  • Valuation PER 15.8X Yield 3.6%. EV/AUM 2.5%
  • Conclusion. The valuations of the fund managers vary modestly, generally trading at 14-17X earnings, while the prospects vary hugely. The prospects for Liontrust are outstanding and it is therefore the one to own. Annoyingly I don’t
  • Argentex (LON:AGFX) – H1 Results

    Share Price 173p

    Mkt cap £196m

    Conflict Disclosure: No Holding

  • Results Revenue up 41% year on year to £13.8m. Adjusted PBT £4.3m, equating to a margin of 46.2%. The company now has 932 active corporate clients with 210 new ones signed in the period. The increase in FX turnover was a modest 16% relative to the 41% increase in revenue, suggesting that the spreads have widened. Cash is £32m and the outlook is excited.
  • Estimates. Upgrades are 21% from the house broker Numis today. EPS goes from 7.1p to 8.7p for March 2020 and from 8.9p to 9.2p next year. Quite how 6% EPS growth can be forecast for next year when revenue growth is running at 41% currently is beyond me. Upgraded forecasts assume 4% revenue growth in H2 after 41% in H1. This looks too low by perhaps 30%
  • Valuation PER is 24.3X before 20% upgrades. Yield 1.2%. Given upgraded forecasts may well be 30% too low the shares are probably cheap.
  • Conclusion These shares are the wrong price because forecasts are far too low. A similar argument applies to Alpha FX which allegedly trades on a PE of 40X.
  • Alpha Financial Markets Consulting (LON:AFM) – H1 Results

    Share Price 193p

    Mkt cap £199m

    Conflict Disclosure: No Holding

  • Results Revenue up 9% to £42.9m and EBITDA up 12.4% to £9.5m. EPS up 10% to 6.82p. Net cash £17.1m. As the company continues its global roll out the number of clients has increased from 252 to 350 over 12 months. US revenues grew 38% and new offices were opened in Denmark and Canada. Outlook is in line with expectations.
  • Estimates Forecasts anticipate £10m of EBITDA in H2 against £9.5m in H1.16% PBT growth in 2021 fading to 9% in 2022.
  • Valuation The PER of 13.8X and yield of 3.6%
  • Conclusion This is not a high growth underlying business but the global roll out coupled with the acquisition strategy have the potential to produce good returns, and the shares are reasonably valued. This looks like a GARP stock for the next few years.

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.